Inventor · disambiguated record
Eric Elenko
Also filed as: ELENKO ERIC
15 granted patents·28 pending applications·80 citations·filing 2009–2025
92Inventor score
Files withUNIV NEW YORK12PureTech Health LLC8PURETECH LYT 100 INC7AKILI INTERACTIVE LABS INC4PURETECH LYT INC4
Top patents by PatentIndex Score
43 records- 0195US11629191B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2022·Granted Apr 18, 2023·4 cites·17 claims
- 0293US10695339B2Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2019·Granted Jun 30, 2020·6 cites·16 claims
- 0393US10344091B2Anti-Galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2018·Granted Jul 9, 2019·9 cites·30 claims
- 0493US10265311B2Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2016·Granted Apr 23, 2019·11 cites·15 claims
- 0591US10450374B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2019·Granted Oct 22, 2019·5 cites·20 claims
- 0691US10369144B2Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2019·Granted Aug 6, 2019·8 cites·16 claims
- 0791US10238643B2Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2017·Granted Mar 26, 2019·9 cites·16 claims
- 0890US10369143B2Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2019·Granted Aug 6, 2019·7 cites·23 claims
- 0986US11122998B2Processor implemented systems and methods for measuring cognitive abilitiesAKILI INTERACTIVE LABS INC·Filed 2016·Granted Sep 21, 2021·9 cites·46 claims
- 1085US11414492B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2019·Granted Aug 16, 2022·2 cites·30 claims
- 1185US2024100039A1Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2023·Application pending·0 cites
- 1282US10559221B2Processor-implemented systems and methods for enhancing cognitive abilities by personalizing cognitive training regimensAKILI INTERACTIVE LABS INC·Filed 2015·Granted Feb 11, 2020·7 cites·40 claims
- 1379US12390150B2Processor implemented systems and methods for measuring cognitive abilitiesAKILI INTERACTIVE LABS INC·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 1478US10272155B2Use of polymeric materials with other substances for improved performanceGELESIS INC·Filed 2015·Granted Apr 30, 2019·3 cites·12 claims
- 1574US2025333506A1Antibodies specific to delta 1 chain of t cell receptorUNIV NEW YORK·Filed 2024·Application pending·0 cites
- 1672US2025114341A1Methods of treating idiopathic pulmonary fibrosis with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 1771US2020323839A1Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPureTech Health LLC·Filed 2020·Application pending·0 cites
- 1870US11696720B2Processor implemented systems and methods for measuring cognitive abilitiesAKILI INTERACTIVE LABS INC·Filed 2021·Granted Jul 11, 2023·0 cites·20 claims
- 1968US2025114340A1Methods of treating interstitial lung diseases and other fibrotic-mediated pulmonary diseases and disorders with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 2066US2025375431A1Methods of treating idiopathic pulmonary fibrosis with deupirfenidonePURE TECH LYT 100 INC·Filed 2025·Application pending·0 cites
- 2165US2025025450A1Methods of treating interstitial lung diseases and other fibrotic-mediated pulmonary diseases and disorders with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 2265US2015265593A1Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPURETECH VENTURES LLC·Filed 2014·Application pending·0 cites
- 2364US2020093810A1Deuterium-enriched pirfenidone and methods of use thereofPureTech Health LLC·Filed 2019·Application pending·0 cites
- 2463US2022178930A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2563US2023255946A1Methods of treating diseases and disorders with deupirfenidonePURE TECH LYT 100 INC·Filed 2023·Application pending·0 cites
- 2663US2022185896A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2763US2009311235A1Use of Polymeric Materials with Other Substances for Improved PerformanceELENKO ERIC·Filed 2009·Application pending·0 cites
- 2862US12084500B2Antibodies specific to delta 1 chain of T cell receptorUNIV NEW YORK·Filed 2020·Granted Sep 10, 2024·0 cites·32 claims
- 2962US2021205283A1Deuterium-enriched pirfenidone and methods of use thereofPURETECH LYT 100 INC·Filed 2021·Application pending·0 cites
- 3061US2023040415A1Methods of treating lymphedema with deupirfenidonePURETECH LYT 100 INC·Filed 2022·Application pending·0 cites
- 3161US2014099356A1Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPURE TECH VENTURES LLC·Filed 2013·Application pending·0 cites
- 3260US2024358690A1Methods of treating idiopathic pulmonary fibrosis with deupirfenidonePURETECH LYT 100 INC·Filed 2024·Application pending·0 cites
- 3359US2025269019A1Anti-galectin-9 antibodies and therapeutic uses thereofPURETECH LYT INC·Filed 2022·Application pending·0 cites
- 3458US2019351061A1Use of polymeric materials with other substances for improved performanceGELESIS LLC·Filed 2019·Application pending·0 cites
- 3557US2024190970A1Anti-galectin-9 antibodies and therapeutic uses thereofPURETECH LYT INC·Filed 2022·Application pending·0 cites
- 3657US2024043543A1Anti-galectin-9 antibodies and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 3757US2024109968A1Anti-galectin-9 antibodies and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 3857US2024182583A1Combination of anti-galectin-9 antibodies and chemotherapeutics for use in cancer therapyPURETECH LYT INC·Filed 2022·Application pending·0 cites
- 3957US2022204629A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 4055US2011020423A1Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activationPURETECH VENTURES·Filed 2010·Application pending·0 cites
- 4154US2024287195A1Anti-galectin-9 antibodies and uses thereof in the treatment of ocular melanomaPURETECH LYT INC·Filed 2021·Application pending·0 cites
- 4253US2023129866A1Methods of treating respiratory disease with deupirfenidonePURETECH LYT 100 INC·Filed 2021·Application pending·0 cites
- 4351US2022332832A1Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeuticsUNIV NEW YORK·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Elenko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →